Stocks are easing lower in early trading on Wall Street Thursday, a day after major indexes briefly flirted with all-time highs before closing mixed. The S&P 500 gave up 0.5% shortly after the opening bell, but it’s still holding on to a gain for the week. Banks and industrial companies were helping lead the way lower, while gains in some Big Tech stocks including Amazon and Facebook helped push the Nasdaq to a small gain. The number of Americans seeking unemployment benefits fell last week to 709,000, the lowest number since March but still very high by historical standards.

THIS IS A BREAKING NEWS UPDATE: AP’s earlier story appears below.

Stocks fell back across Asia on Thursday after gains for big technology shares pushed most Wall Street benchmarks higher.

News of potentially effective vaccines for COVID-19 has been countered by concerns over the logistical challenges of ensuring access to billions of people and over rising caseloads that are leading governments to re-instate restrictions on business and other activities to battle the pandemic.

Vaccine trades reversed to give way to ‘stay home’ trades” as shares of companies that do well when people stay home and work remotely rallied, Mizuho Bank said in a commentary. But it added, “Fact of the matter is, progress on vaccine development is at worst two steps forward one step back, and not one step forward and two steps back on a sustained basis.”

Tokyo’s Nikkei 225 index gained 0.4% to 25,459.13 despite a report that machinery orders fell in September, suggesting weakness in corporate investment.

But the mood was more somber elsewhere in Asia.

Hong Kong’s Hang Seng index fell 0.1% to 26,206.78 and the Shanghai Composite index declined 0.3% to 3,332.24. In Seoul, the Kospi gave up 0.2% to 2,480.95. Australia’s S&P/ASX 200 slipped 0.2% to 6434.60.

The Dow Jones Industrial Average edged 0.1% lower, to 29,397.63, dragged back by weaker prices for companies like American Express and Walt Disney, that had shot up this week after news of a potentially successful vaccine sent travel, entertainment and tourism companies surging.

The Dow declined shortly after news crossed that New York would put restrictions on bars, restaurants and gyms as COVID-19 infections rose in the state.

Markets have been riding a wave of relief over hopes for a potential vaccine to beat back the pandemic. The S&P 500 rose 0.8%, to 3,572.66 and is just 8 points below the record high it set in September. The technology-heavy Nasdaq composite rose 2%, to 11,786.43.

While several significant risks remain for Wall Street broadly, the optimistic case that investors are embracing is that one or more coronavirus vaccines could help corral the virus by the second half of next year, encouraging people to return to life as it was before the pandemic.

All that economic activity would come on top of the tremendous aid that the Federal Reserve and other central banks around the world are pumping into the economy through very low interest rates and massive purchases of bonds. Hope also remains that the U.S. government may eventually deliver some form of support for the economy, though its total size would likely be smaller than if Democrats had swept this month’s elections.

Strategists along Wall Street are raising their forecasts for stock prices on expectations that political control of Washington will remain split between the parties. Republicans look set to keep the Senate, as long as runoff elections go their way in Georgia in January, while Democrats will hold the House of Representatives.

Democrat Joe Biden has clinched enough electoral votes to win the White House, clearing some of the uncertainty that weighed on the market through the vicious campaign. Even though President Donald Trump has refused to concede, investors are ignoring his complaints so far. They’re instead working on the assumption that a split Washington under Biden could keep tax rates low while offering more steady and predictable policies.

Those expected results helped push strategists at Goldman Sachs to raise their forecast for the S&P 500 at the end of this year to 3,700 from 3,600. That would imply another 4.4% climb from Tuesday’s closing level. They expect it to rally another 16% through 2021. But the biggest driver for that is the hope for a return to normal life, rather than what happens in Washington.

In other trading, benchmark U.S. crude oil picked up 19 cents to $41.64 per barrel in electronic trading on the New York Mercantile Exchange. It climbed 9 cents to $41.45 on Wednesday.

Brent crude, the international standard, added 17 cents to $43.97 per barrel.

The U.S. dollar weakened to 105.31 Japanese yen from 105.42 yen. The euro rose to $1.1781 from $1.1776.

AP Business Writers Stan Choe and Ken Sweet contributed.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

New weekly figures show almost 40 million people lost their job since the pandemic

Another 2.44 million Americans filed for initial unemployment benefits last week, bringing the total number of people who lost their job so far during the coronavirus pandemic to almost 40 million. The weekly figures, released Thursday by the Department of…

BP, CRC sign cooperation agreement

BP Plc, the British energy giant, signed a strategic cooperation agreement with China Resources Chemical Innovative Materials Holdings Ltd (CRC) to enhance cooperation on purified terephthalic acid sourcing and the development of the polyester value chain, the London-headquartered company announced…

Apple faces shareholder vote over Chinese app removal policies

(Reuters) – Apple Inc’s (AAPL.O) shareholders on Wednesday will vote on a proposal critical of its moves to remove apps at the request of the Chinese government and calling on the iPhone maker to report whether it has “publicly committed…

Apple sued by Chinese AI company for copyright infringement

Xiao-i filed the lawsuit in a Shanghai court, asking for 10 billion yuan ($1.43 billion) in damages and demanding that Apple cease “manufacturing, using, promising to sell, selling, and importing” products that infringe on the patent. The Chinese firm has argued…